Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Preferred Dividend Payments (2022 - 2025)

Envoy Medical's Preferred Dividend Payments history spans 3 years, with the latest figure at $1.3 million for Q3 2025.

  • For Q3 2025, Preferred Dividend Payments fell 8.33% year-over-year to $1.3 million; the TTM value through Sep 2025 reached $5.1 million, down 83.16%, while the annual FY2023 figure was $1.3 million, N/A changed from the prior year.
  • Preferred Dividend Payments for Q3 2025 was $1.3 million at Envoy Medical, up from $1.3 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $26.4 million in Q4 2023 and bottomed at $1.2 million in Q1 2025.
  • The 3-year median for Preferred Dividend Payments is $1.4 million (2024), against an average of $4.9 million.
  • The largest YoY upside for Preferred Dividend Payments was 8.28% in 2025 against a maximum downside of 9.3% in 2025.
  • A 3-year view of Preferred Dividend Payments shows it stood at $26.4 million in 2023, then plummeted by 94.77% to $1.4 million in 2024, then decreased by 8.33% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Preferred Dividend Payments are $1.3 million (Q3 2025), $1.3 million (Q2 2025), and $1.2 million (Q1 2025).